Table 1 Antibiotic susceptibility profile of biofilm producing staphylococcal isolates by disc diffusion method
From: High level of persister frequency in clinical staphylococcal isolates
Antibiotics | Biofilm producer ( n  = 174) | Biofilm non producer ( n  = 201) | icaAD positive ( n  = 86) | icaAD negative ( n  = 289) | ||||
|---|---|---|---|---|---|---|---|---|
Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | |
Cotrimoxazole | 94 (54.0%) | 80 (46.0%) | 111 (55.2%) | 90 (44.8%) | 48 (55.8%) | 38 (44.2%) | 132 (45.7%) | 157 (54.3%) |
Erythromycin | 46 (26.4%) | 128 (73.6%) | 47 (23.4%) | 154 (76.6%) | 32 (37.2%) | 54 (62.8%) | 61 (21.1%) | 228 (78.9%) |
Chloramphenicol | 165 (94.8%) | 9 (5.2%) | 187 (93.0%) | 14 (7.0%) | 81 (94.2%) | 5 (5.8%) | 271 (93.8%) | 18 (6.2%) |
Tetracycline | 160 (92.9%) | 14 (8.0%) | 179 (89.1%) | 22 (10.9%) | 80 (93.0%) | 6 (7.0%) | 259 (89.6%) | 30 (10.4%) |
Clindamycin | 139 (79.9%) | 35 (20.1%) | 157 (78.1%) | 44 (21.9%) | 74 (86.0%) | 12 (14.0%) | 222 (76.8%) | 67 (23.2%) |
Penicillin | 14 (8.0%) | 160 (92.0%) | 12 (6.0%) | 189 (94.0%) | 6 (7.0%) | 80 (93.0%) | 20 (6.9%) | 269 (93.1%) |
Ciprofloxacin | 89 (51.1%) | 85 (48.9%) | 91 (45.3%) | 110 (54.7%) | 42 (48.8%) | 44 (51.2%) | 138 (47.8%) | 151 (52.2%) |
Cefoxitin | 46 (26.4%) | 128 (73.6%) | 55 (27.4%) | 146 (72.6%) | 29 (33.7%) | 57 (66.3%) | 72 (24.9%) | 217 (75.1%) |
Gentamicin | 128 (73.6%) | 48 (26.4%) | 135 (67.2%) | 66 (32.8%) | 58 (67.4%) | 28 (32.6%) | 205 (70.9%) | 84 (29.1%) |